A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk.
A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk.
复制标题
DOI:
10.1158/1055-9965.epi-10-0151
复制
发表时间:
2010-07
期刊:
影响因子:
--
通讯作者:
Haile RW
中科院分区:
文献类型:
--
作者:
Levine AJ;Figueiredo JC;Lee W;Conti DV;Kennedy K;Duggan DJ;Poynter JN;Campbell PT;Newcomb P;Martinez ME;Hopper JL;Le Marchand L;Baron JA;Limburg PJ;Ulrich CM;Haile RW
Folate-associated one carbon metabolism (FOCM) may play an important role in colorectal carcinogenesis. Variation in FOCM genes may explain some of the underlying risk of colorectal cancer. This study utilized data from 1,805 population-based colorectal cancer cases and 2,878 matched sibling controls from the Colon Cancer Family Registry (C-CFR). We used a comprehensive tagSNP approach to select 395 tagSNPs in 15 genes involved in folate and vitamin B12 metabolism. Genotyping was performed using the Illumina GoldenGate or Sequenom platforms. Risk factor and dietary data were collected using self-completed questionnaires. MSI status was determined using standard techniques and tumor subsite was obtained from pathology reports. The association between SNPs and colorectal cancer was assessed using conditional logistic regression with sibships as the matching factor and assuming a log additive or co-dominant model. In the log additive model, two linked (r2=0.99) tagSNPs in the DHFR gene (rs1677693 and rs1643659) were associated with a significant decrease in CRC risk after correction for multiple testing (OR=0.87; 95% CI=0.71 – 0.94; P=0.029 and OR=0.87 95% CI=0.71 – 0.95, P=0.034 for rs1677693 and rs1643659 respectively. These two linked (r2=0.99) tagSNPs and one tagSNP in the MTR gene (rs4659744) were significantly associated with reduced CRC risk only among individuals not using multivitamin supplements. Overall, we found only moderate evidence that genetic variation in 15 folate pathway genes may affect CRC risk except in non multivitamin users. This study suggests that multivitamin supplement use may modify the association between folate pathway genes and CRC risk in a post folic acid supplemented population.